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Background: Automated radiosynthesizers are vital for routine production of positron-emission tomography tracers
to minimize radiation exposure to operators and to ensure reproducible synthesis yields. The recent trend in the
synthesizer industry towards the use of disposable kits aims to simplify setup and operation for the user, but often
introduces several limitations related to temperature and chemical compatibility, thus requiring reoptimization of
protocols developed on non-cassette-based systems. Radiochemists would benefit from a single hybrid system that
provides tremendous flexibility for development and optimization of reaction conditions while also providing a
pathway to simple, cassette-based production of diverse tracers.
Methods: We have designed, built, and tested an automated three-reactor radiosynthesizer (ELIXYS) to provide a
flexible radiosynthesis platform suitable for both tracer development and routine production. The synthesizer is
capable of performing high-pressure and high-temperature reactions by eliminating permanent tubing and valve
connections to the reaction vessel. Each of the three movable reactors can seal against different locations on
disposable cassettes to carry out different functions such as sealed reactions, evaporations, and reagent addition. A
reagent and gas handling robot moves sealed reagent vials from storage locations in the cassette to addition
positions and also dynamically provides vacuum and inert gas to ports on the cassette. The software integrates
these automated features into chemistry unit operations (e.g., React, Evaporate, Add) to intuitively create synthesis
protocols. 2-Deoxy-2-[18F]fluoro-5-methyl-β-L-arabinofuranosyluracil (L-[18F]FMAU) and 2-deoxy-2-[18F]fluoro-β-D-
arabinofuranosylcytosine (D-[18F]FAC) were synthesized to validate the system.
Results: L-[18F]FMAU and D-[18F]FAC were successfully synthesized in 165 and 170 min, respectively, with decay-
corrected radiochemical yields of 46% ± 1% (n = 6) and 31% ± 5% (n = 6), respectively. The yield, repeatability, and
synthesis time are comparable to, or better than, other reports. D-[18F]FAC produced by ELIXYS and another
manually operated apparatus exhibited similar biodistribution in wild-type mice.
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Conclusion: The ELIXYS automated radiosynthesizer is capable of performing radiosyntheses requiring demanding
conditions: up to three reaction vessels, high temperatures, high pressures, and sensitive reagents. Such flexibility
facilitates tracer development and the ability to synthesize multiple tracers on the same system without
customization or replumbing. The disposable cassette approach simplifies the transition from development to
production.
Keywords: Automated radiosynthesis; Fluorine-18; High-pressure synthesis; Multipot synthesis; Disposable cassette;
FACBackground
Positron-emission tomography (PET) has opened the door
to in vivo imaging for the purposes of non-invasive disease
detection, cancer staging, and drug efficacy screening [1].
2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) is the most
commonly utilized PET tracer due to its relative ease of
production, manageable half-life, and ubiquitous applica-
tion [2,3]. The increased demand for [18F]FDG has led to
the development of many automated radiosynthesizers to
lower its cost, enable its production at many different
sites, and reduce the radiation exposure to the radio-
chemist [4,5].
Though automated synthesis of [18F]FDG is extremely
valuable, there are many 18F-labeled PET tracers that
await an automated synthesizer to streamline their pro-
duction [6]. Some of these tracers require high pres-
sures, complicated chemistry, and/or corrosive reagents
that make automation difficult. For example, nucleoside
analogs that have been used in imaging cell proliferation
and reporter gene expression [7-9] and as possible
screening agents for chemotherapy drug efficacy [10]
often require high-temperature reactions in volatile sol-
vents. Several attempts have been made to automate the
syntheses of these tracers on commercially available
radiosynthesizers. Often, these attempts have required
modifications to the chemistry (e.g., use of alternative
solvents or reduced temperatures) to reduce the pres-
sures involved and avoid exceeding the limitations of the
radiosynthesizers [8,11-16].
To overcome these synthesizer limitations, we previously
developed a platform with movable components that seals
the reaction vessel against an inert stopper during reactions
to avoid exposure of tubing and valves to high pressures
[17]. We further developed this system into a modular
computer-controlled platform [18] and demonstrated the
successful synthesis of 2-deoxy-2-[18F]fluoro-5-methyl-β-L-
arabinofuranosyluracil (L-[18F]FMAU) and 2-deoxy-2-[18F]
fluoro-β-D-arabinofuranosylcytosine (D-[18F]FAC). We de-
scribe here the integration of three of these modules into
an automated synthesizer [19] and the addition of numer-
ous improvements and features to increase the reliability
and user-friendliness of the system. The ELIXYS three-
reactor synthesizer is designed to use disposable cassettesfor ease of setup and operation and to facilitate rapid
transition from tracer development to routine produc-
tion. The system also has an integrated, automated re-
agent handling robot to deliver sensitive reagents from
sealed vials on demand. This paper describes in detail
this radiosynthesizer and its characterization and valid-
ation via the synthesis of D-[18F]FAC and L-[18F]FMAU.




The hardware and software of the ELIXYS radiosyn-
thesizer were designed to be user-friendly and accommo-
date a wide variety of synthesis protocols by allowing the
user to customize the reagents, reaction times, tempera-
tures, and intermediate purifications in a manner that fo-
cuses on organizing automated synthesis steps into ‘unit
operations.’ These chemistry operations serve as intuitive
building blocks from which diverse syntheses can be
constructed without the need for reconfiguring the instru-
ment to perform different syntheses.
The radiosynthesizer (Figure 1) has three key compo-
nents working in concert: a set of three reactors (Figure 2),
a reagent and gas handling robot (Figure 3), and dispos-
able cassettes (Figure 4). The cassettes store reagents in
sealed vials, act as the primary fluid path for both reagents
and gas flow, and have a rubber gasket affixed to the
bottom for sealing the top of glass reaction vessels. Cas-
settes accelerate setup, eliminate the need for cleaning,
and facilitate a natural transition from tracer develop-
ment to routine production. The reactor subassemblies
provide temperature control of the reaction vessel and
movement of the vessel to various positions beneath the
cassette designed for evaporations, sealed reactions,
reagent addition, and transfer of product. Once aligned
at the proper position, the reactor is raised to seal the
top of the vessel against the gasket on the underside of
the cassette. The two-axis reagent and gas handling
robot supplies inert gas (to drive fluid movement and
assist with evaporations) and vacuum (to remove vapor
during evaporations) to special interfaces on the top of
the cassettes. A gripper mounted to the same robot
Figure 1 ELIXYS synthesis module. (a) Schematic, (b) photograph, and (c) enclosure with dimensions of the ELIXYS radiosynthesizer. The three
reactors can be moved back and forth and raised to seal the vessel against various positions on the gasket at the bottom of the disposable
cassettes to perform various unit operations. A reagent and gas handling robot manipulates reagent vials and supplies inert gas and vacuum for
all three cassettes.
Figure 2 Detailed view of a single reactor. (a) 3D view of the reactor subassembly. (b) Side view (bottom) with a cross section through the
spring-loaded chuck (top).
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Figure 3 The reagent and gas handling robot. (a) Overview. (b) Close-up of the vial gripper and gas supplier head. The head moves in the
x- and y-directions to access reagent vial positions and inert gas and vacuum ports on the three cassettes. The vial gripper and gas supplier can
independently move in the z-direction.
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Reactor
A 5-mL glass V-vial (W986259NG, Wheaton, Millville, NJ,
USA) is placed into the reactor and held within a three-
segment spring-loaded ‘chuck’ (Figure 2). The segments
press firmly against the vial to ensure excellent thermal
contact and thus efficient heat exchange between the re-
actor and the glass vial. Each segment has one 100-W cart-
ridge heater (CIR-1021-120V-100W-ST-A, Valin, San Jose,
CA, USA) and a K-type thermocouple (HTTC72-K-116U-
1.25-UNGR, Omega Engineering; Stamford, CT, USA) for
individual feedback control of the reactor temperature.
The maximum reactor temperature is 185°C, but we are
investigating alternative types of fittings to enable an even
higher operating temperature. Since we typically observed
very similar temperature response in all three segments,
the reactor temperature at any given moment is considered
equal to the average of the three temperature readings
from the thermocouples. Active liquid cooling is achieved
by pumping room-temperature coolant (propylene/
ethylene glycol and water mixture) through cooling
channels in all three reactors in series using a liquid
pump (8030-863-236, Steam Brite, San Antonio, TX,
USA) and then through a radiator with three 140-mmfans (HX-CU1403V, Frozen CPU, East Rochester, NY,
USA).
Each reactor is situated beneath a cassette and actu-
ated back and forth among various positions (Figures 4
and 5). In each position, the reactor can be raised using
pneumatic cylinders to seal the top of the reaction vessel
against a portion of the gasket affixed to the bottom of
the cassette. This movement allows for the reaction ves-
sel and fluid path to be dynamically configured for dif-
ferent unit operations (Figure 5). For example, in one
position, tubing is present to deliver reagents to the re-
actor; in another position, there is no tubing, allowing
for a reaction under sealed conditions. Permanent tubing
and valve connections to the reaction vessel are the root
cause of the reaction pressure limitations of most syn-
thesizers [17]. The ability to move the reaction vessel to
a dedicated sealed reaction position eliminates these lim-
itations and enables compatibility with higher pressures.
To ensure reliable operation, the position of the reaction
vessel is monitored via feedback from the linear actuator
and the raised or lowered state is detected with Hall ef-
fect sensors (D-M9NWL, SMC Corporation, Noblesville,
IN, USA).
We have mounted a camera (PC213XS, Super Circuits,
Austin, TX, USA) behind the reactor, which is especially
helpful during synthesis development to monitor liquid
Figure 4 Overview of the disposable cassette. (a) The top view of the disposable cassette illustrates the locations for reagent addition and
storage along with gas ports for the gas supplier to provide vacuum and inert gas. Tubing extends out of the inlet-tubing ports for radioisotope
and external additions. (b) Bottom view. The reactor seals against various positions on a PTFE-coated silicone gasket underneath the cassette to
perform various unit operations (Evaporate, React, Add, and Transfer). Each cassette contains three stopcock valves and has a dip tube for
transferring products to purification cartridges, subsequent cassettes, or the HPLC injection valve.
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reaction progression, to confirm reagent additions and
transfers, and for visual inspection of the eluate post
purification. The final component of the reactor is a mag-
net mounted on a DC motor (803-313-5858, KALEJA
Elektronik GmbH, Alfdorf, Germany) to rotate a remov-
able magnetic stir bar inside the reaction vessel.
Reagent and gas handling robot
A pneumatically actuated vial gripper (Figure 3) that is
affixed to a three-axis motion system grasps reagent vials
and moves them from storage locations to addition loca-
tions (and vice versa) in the cassettes. The x- and y-axis
motions are performed by a pair of linear actuators. The
z-axis motion is accomplished with a pneumatic cylin-
der. Sealed reagent vials are installed upside-down in the
cassettes (Figure 5).
A gas supplier, comprised of inert gas and vacuum sup-
ply ports, is mounted on a second pneumatic z-axis
actuator affixed near the vial gripper (Figure 3). In the pre-
vious prototype to the ELIXYS [21], the cassettes each had
multiple inputs on their bottom surface for inert gas and
vacuum that mated with corresponding ports on the
synthesizer. This system was prone to failure due to thelarge number of connections and the difficulty in main-
taining reliable gas-tight seals during operation. With a
single, movable gas supplying robot in ELIXYS, a large
number of valves and seals are eliminated, increasing the
reliability of the system. The gas supplier is lowered to en-
gage respective vacuum and inert gas ports on top of the
cassette (Figure 4). The cassettes contain a rubber gasket
around each port to form a gas-tight seal with the port on
the robot. The vacuum port is mounted at a height above
the inert gas port and on a spring-loaded mechanism to
ensure proper sealing of both ports when needed and to
avoid collision of the vacuum portion of the gas supplier
when vacuum is not needed.
The use of Hall effect sensors as feedback mechanisms
on z-axis pneumatic actuators and the vial gripper en-
able detection of missing reagent vials and prevent x-
and y-axis motions if the vial gripper and gas supplier
are not in their raised, clearance positions. An in-line
check valve (CI-5C, Bio Chem Fluidics, Boonton, NJ,
USA) is installed on the inert gas line close to the deliv-
ery point to eliminate backflow of vapor. A cold trap
(CG451501, Chemglass, Vineland, NJ, USA), cooled in a
small Dewar (10-195A, Fisher Scientific, Pittsburg, PA,

































































Figure 5 Fluid diagram for each unit operation. (a) Side profile schematic of the disposable cassette. The remaining figures show the
schematic of cassette fluid paths for each unit operation. (b) Evaporate. Gas supplier provides vacuum and inert gas flow while the reactor is
heated. (c) React1. First fully sealed reaction position. (d) React2. Second fully sealed reaction position. (e) Add. Vial gripper presses a reagent vial
into one of two addition positions where two needles pierce the vial's septum; one needle allows inert gas flow from the gas supplier through
the inert gas port, and the other needle allows the reagent to flow into the reaction vessel. (f) Transfer. Contents of one reaction vessel can be
transferred to another cassette, the HPLC valve, or to a purification cartridge. (g) Radioisotope handling. [18F]fluoride trap and release can be
done using two of the built in stopcock valves.
Lazari et al. EJNMMI Research 2013, 3:52 Page 6 of 13
http://www.ejnmmires.com/content/3/1/52is installed in-line between the vacuum port and the in-
tegrated vacuum pump (VP0140-V1006-D2-0511, Medo
USA Inc., Roselle, IL, USA) with a digital vacuum gauge
(ZSE30-N7L, SMC Corporation).
Disposable cassettes
Cassettes (Figure 4) are designed to contain all dispos-
able components and fluid paths, eliminating the need
to clean or customize the apparatus between syntheses.These molded polyurethane cassettes contain stainless
steel needles (Vita Needle, Needham, MA, USA), tubing,
chemically inert three-way stopcock valves (EW-31200-80,
Cole-Parmer, Vernon Hills, IL, USA), and a custom poly-
tetrafluoroethylene (PTFE)-coated silicone gasket (Spe-
cialty Silicone Products, Inc., Ballston Spa, NY, USA, and
Cannon Gasket, Upland, CA, USA) against which the
reaction vessel is sealed. The fluid paths are shown in
Figure 5. Preassembled cassettes slide along rails into the
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Accurate positioning is ensured by the mating of align-
ment features and by the engagement of stopcock valves
with adapters affixed to rotary pneumatic actuators
(CRB2BW20-180S, SMC Corporation).
Each cassette has 11 reagent vial storage positions that
each house one 13-mm crimped septum-cap vial (with a
maximum volume of 3 mL) in an inverted configuration.
Three additional vial positions contain dual upward-
pointing needles to pierce the septa for delivery of fluids
from the reagent vials. One needle in each position is
used for fluid delivery; the other connects to an inert gas
port on top of the cassette, which allows pressurization
of the vial by the gas supplier. In the two reagent addition
positions, the fluid delivery needles output directly to the
underside of the cassette where the reaction vessel is
sealed for reagent addition. The fluid delivery needle in
the third position (for eluent addition) is connected via in-
ternal tubing to a stopcock valve.
Two of the stopcock valves are used to reconfigure the
internal fluid paths to perform cartridge trap and release,
such as for the preparation of an incoming radioisotope,
e.g., solvent exchange of [18F]fluoride to recover [18O]
H2O. The upstream valve selects between incoming fluid
from an external addition line (trapping) or the eluent
addition position (release). The output of the first stop-
cock is connected via tubing to a cartridge. The output
of the cartridge is connected to a second tube that feeds
into a second stopcock valve that selects whether the
fluid is directed to a built-in collection vial (trapping) or
a line into the position where the reaction vessel is
sealed for reagent addition (release). The third stopcock





































Figure 6 ELIXYS control system schematic. Schematic of control compo
synthesis module.product before transfer to the next reaction vessel. The
purification cartridge is installed between the dip tube
(for removal of crude product from the reaction vessel)
and the tube leading to the stopcock. The outputs of the
stopcock are connected to a built-in waste vial (trap-
ping, washing) or an external output line (release) that
can be plugged into the next cassette or the high-
performance liquid chromatography (HPLC) injection
valve. Cartridges can be mounted on clips near the front
of the cassettes for convenience.
Control system
Supporting electronics, pneumatics, and cooling system
are enclosed in a separate control system (Figure 6). The
system is controlled by a Linux server, which communi-
cates with a programmable logic controller (PLC; CJ2M-
CPU31, Omron, Kyoto, Japan) over Ethernet, which in
turn drives most of the subsystems including linear
actuators, pneumatics, cooling, heating, stirring, and
HPLC injection, in addition to reading radioactivity de-
tectors affixed to each reactor. The PLC accomplishes
this through several expansion modules (CJ1W-DRM21,
CJ1W-AD081-V1, CJ1W-ID261, CJ1W-DA08V, CJ1W-
OD261, CJ1W-TC001, Omron).
Five motor controllers are connected to a RoboNET
network controller gateway unit (RGW-DV, IAI America
Inc., Torrance, CA, USA) in the synthesis module, which
is in turn controlled by the PLC. Two of these are pulse
motor controllers (RPCON-42P, IAI America Inc.) that
drive the x- and y-axes of the reagent and gas handling
robot, a 350- and 100-mm-stroke two-axis linear servo-
motor (RCP2-SS7R-I-42P-12-350-P1-007L-ML-SP, RCP3-
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nents, actuators, and sensors in the control system and
Table 1 List of unit operations available to build a
synthesis sequence
Unit operation Description of function
INITIALIZE Initializes hardware
TRAPF18 Trap [18F]fluoride from cyclotron or preloaded
external vial
ELUTEF18 Elute [18F]fluoride with a reagent from the
cassette
ADD Add a reagent from any cassette
EVAPORATE Evaporate the contents of a reactor
REACT Fully seal a reaction vessel for a reaction
TRANSFER Transfer solvents and reaction products from
one reaction vessel to another, often using
purification cartridges in between
TRANSFERTOHPLCa Transfers the contents of the reaction vessel to
the HPLC injection loop
EXTERNALADD Move a reactor to its add position for externally
adding a reagent
MIX Mix the contents of a reaction vessel
INSTALL Move a reactor to a position for reaction vessel
removal and/or installation
MEASURERADIATIONa Measures the radiation level of a given reactor
aThese unit operations are currently under development.
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(RACON-5, IAI America Inc.) driving the linear servo-
motor (RCP3-SA3R-I-28P-4-200-P1-P-ML, IAI America
Inc.) for the y-axis motion of each reactor.
A source of inert gas is dynamically regulated in soft-
ware from >60 psig down to two different pressures by
two analog pressure regulators (ITV1030-31N2L4-Q,
SMC Corporation). One pressure line drives the pneu-
matic actuators (typically set to 60 psig), and the other
pressure line drives gas flow for liquid transfers and
evaporation (typically 3 to 15 psig). The two lines are
distributed to actuators and the gas supplier through so-
lenoid valve banks located in the synthesis module. The
higher pressure line is used to raise and lower the reac-
tion vessels using pneumatic cylinders (NCDGBN20-
0300, SMC Corporation), turn the stopcock valves via
the rotary pneumatic actuators (CRB2BW20-180S, SMC
Corporation), raise and lower the two z-axis actuators
(MXS8-50, SMC Corporation) for the vial gripper and
gas supplier, and open and close the vial gripper (MHS2-
16D, SMC Corporation). The lower pressure line feeds
into the gas supplier that seals to the gas inlet gaskets
on top of the cassettes, and an external line that can be
used to transfer [18F]fluoride from a source vial into the
anion exchange cartridge on the cassette, for example.
The control system also houses a number of other
components: the solid-state relays (G6B-4BNDDC12,
Omron) to switch the heaters on and off for reactor
temperature control, the cooling system (coolant pump,
reservoir, and radiator fans), a video server (VS8401,
Vivotek, San Jose, CA, USA) to encode the analog signals
from the reactor cameras into video streams available to
the Linux server via Ethernet, and an electronically con-
trolled HPLC injection valve (MHP7900-500-1, Rheodyne,
Rohnert Park, CA, USA) connected to a separate semi-
preparative HPLC system. Loading of the HPLC loop is
performed manually but in the future will be performed
automatically [22].
System operations
The ELIXYS performs automated syntheses by complet-
ing a sequence of chemistry unit operations (Table 1).
The interactions among the ELIXYS subsystems and
disposable cassettes to carry out each operation are de-
scribed in the following subsections.
Radioisotope handling
For radiochemistry with [18F]fluoride, a preconditioned
quaternary methylammonium (QMA) cartridge is in-
stalled with Luer fittings between two tubes coming from
the cassette, and the source of [18F]fluoride (vial or cyclo-
tron) is connected to another tube. (If a vial is used, it is
pressurized by an inert gas line controlled by the system.)
During trapping, the [18F]fluoride source solution flowsthrough the cartridge and [18O]H2O is collected in a re-
covery vial. To perform elution, the two stopcock valves
are switched and the reagent and gas handling robot
drives the eluent from the eluent addition position of the
cassette through the cartridge and into the reaction vessel.
Multiple elutions or rinses can be performed to increase
the efficiency of [18F]fluoride collection. PEEK tubing was
used for all fluid paths involving [18F]fluoride to maximize
specific activity [23]. For other radioisotopes, a cartridge
may not be necessary and can be bypassed. Radioisotopes
may be added to any of the three reactors independently.
Reagent handling
To add a particular reagent, the vial gripper moves to
the reagent storage position and then lowers itself to a
position where it can grasp and lift the vial before mov-
ing it to the designated reagent addition location on the
specified cassette. To deliver the reagent to the reaction
vessel, the gas supplier lowers, the inert gas valve opens,
and the vial gripper lowers to place the vial down onto a
pair of needles in one of the two reagent addition posi-
tions or in the eluent addition position, pressurizing the
vial and transferring its contents. The required time for
addition of a reagent is generally determined by repeat-
edly measuring the time needed for complete transfer of
the desired liquid and volume at the desired pressure,
taking the maximum time value, and multiplying by a
safety factor. The entire contents of the reagent vial are
delivered at once. After addition is complete, the vial
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engages, and the vial is returned to its original storage
position. The low-level steps of the Add unit operation
are summarized in Additional file 1: Figure S1.
Like all fluidic systems, there are losses associated with
dead volumes during liquid transfers. Initial character-
ization revealed that a small amount (120 ± 20 μL, n =
120) of the liquid remains in the reagent vial after
addition. To account for this loss, additional reagent can
be loaded beforehand into the crimped vials.
Reactions
To maintain high internal pressure during superheated
reactions, the reaction vessel is sealed by firmly pressing
upward against the gasket on the bottom of the cassette.
Each cassette has two independent reaction positions to
support up to two separate sealed reactions in each reac-
tion vessel (Figure 5). To characterize the seal integrity,
approximately 1 mL of anhydrous acetonitrile was sealed
and heated at 165°C for 1 h. In all experiments, <14 μL
of volume was lost (<1.5%). We believe the actual loss of
vapor to be even lower because often some small drops
of condensed solvent were observed on the gasket where
the reaction vessel had been sealed.
Using a hypodermic needle thermocouple (HN-7-K-
TEF, J-KEM Scientific, Saint Louis, MO, USA) pierced
through the gasket, we have also compared the internal
liquid temperature profile of the reaction vessel contents
in the ELIXYS to the profile inside the same vessel
immersed in a traditional preheated oil bath (Additional
file 1: Figure S2). We found the heating rates and internal
liquid temperature to be comparable, but the active liquid
cooling of the ELIXYS results in a more rapid decrease in
temperature after heating.
After reagents are loaded into the reaction vessel, a re-
action can be performed by sealing the vessel against a
sealing position on the gasket of the cassette (Figures 4
and 5). The reactor is then heated to the desired
temperature, with optional stirring. Once the desired el-
evated temperature is reached in the heating jacket,
heating and stirring are continued for the desired reac-
tion time. After this time elapses, the heaters are turned
off and the cooling pump is activated until the heating
jacket reaches the desired reduced temperature. Add-
itional cooling of the reaction vessel is necessary to
ensure the internal liquid temperature is sufficiently
lowered; the desired additional time for cooling can be
programmed in the software.
Evaporations
Evaporation of solvents occurs by sealing the reaction
vessel against the gasket of the cassette at the evaporate
position (Figures 4 and 5). The vessel is heated with the
option of stirring, and the gas supplier provides bothvacuum (to remove vapor) and inert gas (to assist with
vapor removal) through the ports on the cassette. The
required time for evaporation is generally determined
by measuring the maximum time needed for complete
evaporation of the solvent from the desired mixture and
multiplying by a safety factor. After the desired eva-
poration time, the reactor is cooled. The low-level steps
of the Evaporate unit operation are summarized in
Additional file 1: Figure S3.
Transfer and purification
Sep-Pak purification cartridges (Sep-Pak), e.g., silica, C18,
etc., are connected to designated Luer fittings on the cas-
sette. A dip tube (e.g., made of Teflon® tubing with an out-
side diameter (OD) of 1/8 in.) is built into the cassette to
act as the fluid path for the transfer of crude products.
Tubing with an OD of 1/8 in. is necessary when transfer-
ring synthesis products that produce precipitates, but 1/16
in. tubing may be installed for smaller volume transfers.
The transfer unit operation begins with the reaction vessel
sealing against the transfer position on the cassette
(Figures 4 and 5). The gas supplier provides inert gas to
pressurize the reaction vessel. This moves the fluid
through the dip tube and to the Sep-Pak. After the Sep-
Pak, a dedicated stopcock valve in the cassette switches
between a fluid path towards a waste collection vial in-
stalled on the cassette and a tube that can be plumbed to
the input of the next cassette. Often, the first step is to
trap the crude product onto the Sep-Pak and allow the re-
sidual solution to collect in the waste container. The
stopcock position is switched, and elution of the desired
product into the next reaction vessel is then performed by
adding the elution solvent to the first reaction vessel and




No-carrier-added [18F]fluoride was produced by the
(p,n) reaction of [18O]H2O (98% isotopic purity, Medical
Isotopes, Pelham, NH, USA) in a RDS-112 cyclotron
(Siemens, Knoxville, TN, USA) at 11 MeV using a 1-mL
tantalum target with Havar foil. 2-O-(Trifluoromethyl
sulfonyl)-1,3,5-tri-O-benzoyl-alpha-D-ribo-furanose, 2-O-
(trifluoromethylsulfonyl)-1,3,5-tri-O-benzoyl-alpha-L-ribo-
furanose, bis(trimethylsilyl)cytosine, and 5-methyl-2,4-bis
[(trimethylsilyl)oxy]pyrimidine were purchased from ABX
(Radeberg, Germany). Ethanol (200 proof) was purchased
from the UCLA Chemistry Department (Los Angeles, CA,
USA). Hydrochloric acid (1 N) was purchased from Fisher
Scientific (Pittsburg, PA, USA). Anhydrous grade sol-
vents and all other reagents were purchased from
Sigma-Aldrich (Milwaukee, WI, USA). All reagents were
used as received. QMA (WAT023525) and silica
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chased from Waters (Milford, MA, USA). The QMA
cartridge was preconditioned with 10 mL of 1 M potas-
sium bicarbonate followed by 10 mL of 0.1-μm-filtered 18
MΩ water, and the silica cartridges were preconditioned
with 10 mL of anhydrous hexane.
Chromatography
Semi-preparative HPLC was performed with a WellChrom
K-501 HPLC pump (Knauer, Berlin, Germany), reversed-
phase Gemini-NX column (5 μm, 10 × 250 mm,
Phenomenex, Torrance, CA, USA), UV detector (254 nm,
WellChrom Spectro-Photometer K-2501, Knauer), and
gamma radiation detector and counter (B-FC-3300 and
B-FC-1000; Bioscan Inc., Washington, DC, USA). The
mobile phase for D-[18F]FAC was 1% ethanol in 10 mM
ammonium phosphate monobasic (flow rate 5 mL/min;
retention time 15 min) and for L-[18F]FMAU was 4%
acetonitrile in 50 mM ammonium acetate (flow rate
5 mL/min; retention time 20 min). Analytical HPLC was
performed on a Knauer Smartline HPLC system with a
Phenomenex reversed-phase Luna column (5 μm, 4.6 ×
250 mm) with in-line Knauer UV (254 nm) and gamma
radiation coincidence detector and counter (B-FC-4100
and B-FC-1000). The analytical HPLC mobile phase for
D-[18F]FAC was 10% ethanol in 50 mM ammonium
acetate (flow rate 1 mL/min; retention time 4 min) and
for L-[18F]FMAU was 10% acetonitrile in 50 mM ammo-
nium acetate (flow rate 1 mL/min; retention time 7 min).
All chromatograms were collected using a GinaStar
analog-to-digital converter (raytest USA, Inc., Wilming-
ton, NC, USA) and GinaStar software (raytest USA, Inc.)
running on a PC.a
b
d
Figure 7 Reaction mechanisms of D-[18F]FAC and L-[18F]FMAU. Synthe
of the two tracers differs only in the ribose sugar (a vs. d) and base coupli
(shown here) are collected as final products (c and f).Synthesis protocol
Synthesis protocols for D-[18F]FAC and L-[18F]FMAU
(Figure 7) were nearly identical, differing only in precur-
sors and HPLC mobile phases, and were programmed
using the ELIXYS drag-and-drop software interface [20].
The protocols are a minor adaptation from the literature
[17,18]. A summary of the reagents and unit operations
used to synthesize the tracers can be found in Additional
file 1 (Additional file 1: Tables S1 and S2). Upon comple-
tion of each synthesis, the crude product was purified by
semi-preparative HPLC and the desired product (beta
form, structures c and f in Figure 7) was collected and a
sample taken for verification and specific activity analysis
by analytical HPLC.
In vivo imaging
Four conscious C57BL/6 mice were injected at the
UCLA Ahmanson Translational Imaging Division with
0.74 MBq (20 μCi) of D-[18F]FAC (tail vein, 60-min up-
take) produced on the ELIXYS. Two days afterward, the
same four mice were injected with D-[18F]FAC pro-
duced at the UCLA Biomedical Cyclotron Facility using
a manually operated apparatus [17]. Before scanning,
mice were anesthetized with 2% isoflurane and placed in
a dedicated imaging chamber designed for use with both
the PET and CT systems. Ten-minute whole-body PET
images were acquired using a GENISYS4 (Sofie Biosciences
Inc., Culver City, CA, USA) and then transferred to the
micro-CT (ImTek Inc., Knoxville, TN, USA) for an 8-min
scan. Parameters for CT acquisition were 70 kVp, 500 μA,
and an exposure time of 480 s. A Feldkamp reconstruction
algorithm was applied. PET/CT images were fused and an-





ses of D-[18F]FAC (top) and L-[18F]FMAU (bottom). Synthesis protocol
ng (b vs. e) precursors. During HPLC purification, only the beta form
Figure 8 In vivo imaging of D-[18F]FAC. (a) PET/CT imaging of
two of the four C57BL/6 mice using D-[18F]FAC produced from
either ELIXYS or a manually operated apparatus (TH, thymus; GI,
gastrointestinal tract; SP, spleen; BL, bladder; BM, bone marrow). (b)
Percent injected dose per gram (% ID/g) was normalized to muscle
tissue and averaged for the four mice in each organ of interest.
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spleen, and thymus were normalized to muscle tissue
and respectively averaged over the four mice. Imaging
data are presented in Figure 8.
All animal experiments were approved by the UCLA
Animal Research Committee and were performedTable 2 Comparison of synthesis data
Radiotracer Reference Radiochemical yield (%)
[18F]FAC Amarasekera et al. [17] 39 ± 5 (n = 13)
This work 31 ± 5 (n = 6)
[18F]FMAU Alauddin et al. [11] 20 to 30
Mangner et al. [24] 42.1 ± 12.1 (n = 9)
Li et al. [16] 12 ± 3 (n = 4)
Amarasekera et al. [17] 35 ± 6 (n = 10)
This work 46 ± 1 (n = 6)
Yield, synthesis duration, and specific activity of two tracers produced with the ELIX
specified, but presumably includes HPLC purification; btime point not specified, butaccording to the guidelines of the Division of Labora-
tory Animal Medicine at UCLA.
Results and discussion
To validate the functionality of the synthesizer, the
three-reactor syntheses of D-[18F]FAC and L-[18F]FMAU
were performed. The maximum radioactivity used in the
syntheses was approximately 35 GBq. Decay-corrected
radiochemical yield, duration of synthesis, and specific
activity are listed in Table 2. Synthesis times and yields
are comparable to or better than other reports found in
the literature [11,16,17,24].
The ELIXYS currently supports PET tracer production
in our preclinical facility, and therefore, products were
confirmed by coinjection with cold standard into the
analytical HPLC, and radiochemical purity was found to
be >99% for both tracers. However, numerous batches
of D-[18F]FAC (as well as other tracers) have been
subjected to the complete set of quality assurance tests re-
quired for clinical use and have passed. These tests in-
clude residual solvent analysis via gas chromatography,
Kryptofix K222 spot test, filter integrity test, radionuclide
identity by half-life and energy, visual inspection of optical
clarity, as well as pyrogenicity and sterility. We are cur-
rently updating the software for compliance with current
good manufacturing practice, and the updated system will
be placed in a clinical facility for production of tracers
under 21 CFR 212 regulations or USP 823 guidelines.
In vivo imaging using D-[18F]FAC produced on ELIXYS
and that produced by the UCLA Biomedical Cyclotron
Facility in a manually operated apparatus [17] showed
comparable images and uptake as expected in the gastro-
intestinal tract (GI) and hematopoietic organs (Figure 8)
[25]. Though there appears to be higher ‘noise’ (muscle
uptake) in the images of mice injected with ELIXYS-
produced D-[18F]FAC, there is also higher ‘signal’ (organ
uptake). Indeed, whole-body regions of interest excluding
the tail showed that the total amount of activity was
higher in the images of the mice injected with the
ELIXYS-produced tracer. We suspect that there may have
been variations in the injections, e.g., more tracer left inDuration of synthesis (min) Specific activity (GBq/μmol)
~240 >37
165 37 to 44
210 to 240a 85.1
160 111b
150a 14.2 ± 1.2
~240 >37
170 100 to 170
YS radiosynthesizer compared to values found in literature. aEndpoint not
presumably at time of injection.
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of activity in circulation. To remove these biases, organ
uptake was normalized to a region of muscle tissue that
showed no significant uptake.
The disposable cassette approach has allowed for mul-
tiple tracers in addition to D-[18F]FAC and L-[18F]
FMAU to be readily synthesized, including 2-deoxy-2-
[18F]fluoro-5-ethyl-β-D-arabinofuranosyluracil (D-[18F]
FEAU) [26] as well as 2-[18F]fluoro-2-deoxy-D-glucose
([18F]FDG), 3-deoxy-3-[18F]fluoro-L-thymidine ([18F]FLT),
[18F]fallypride, 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)-
guanine ([18F]FHBG), and N-succinimidyl-4-[18F]fluoro-
benzoate ([18F]SFB) (results to be published separately), by
simply switching cassettes and software programs. No
hardware or plumbing changes were needed between
productions of different tracers.
Conclusion
We have developed a new, versatile radiosynthesizer that
is suitable both for reaction development and routine
production of PET tracers. The ELIXYS synthesizer con-
tains very few wetted fittings and tubing compared to
other radiosynthesizers, yet through the unique use of
motion to implement dynamically reconfigurable fluid
paths, it is capable of diverse syntheses without hard-
ware customization. It has been designed to be capable
of diverse syntheses requiring up to three reaction ves-
sels, high-pressure and high-temperature reactions, as
well as sensitive, corrosive, and volatile reagents.
To validate this new system, the three-reactor synthe-
ses of D-[18F]FAC and L-[18F]FMAU were demonstrated,
and yields and synthesis times were found to be compar-
able to other reports. Several additional tracers of vary-
ing complexity have also been successfully synthesized
on this system.
Additional file
Additional file 1: Figure S1. Flowchart of ‘Add’ unit operation.
Sequence of low level steps required to add the contents of a reagent
placed in the second reagent position of the first cassette to the first
reaction vessel. The user need only choose the ‘Add’ unit operation and
set a few parameters; the low level details are carried out automatically.
Figure S2. Internal temperature of liquid in the reaction vessel during
heating and cooling in the ELIXYS system and in an oil bath. Figure S3.
(a) Sequence of low level steps required to evaporate the contents of
the first reaction vessel. (b) Gas supplier is positioned over the vacuum
and inert gas ports of the cassette. (c) Gas supplier is lowered, supplying
vacuum and inert gas to the reaction vessel. Table S1. List of reagents
installed into the three cassettes to synthesize D-[18F]FAC and L-[18F]
FMAU. Externally added reagents (HBr and DCE) do not have designated
locations on the cassette and can be programmed with the ExternalAdd
unit operation. Table S2. List of unit operations to synthesize both
D-[18F]FAC and L-[18F]FMAU on the ELIXYS.
Competing interests
RMvD and MEP own equity in Sofie Biosciences, Inc. GJS and MDM are
employees of Sofie Biosciences, Inc. SBC and KMQ have worked for SofieBiosciences, Inc. as paid consultants. ML, JC, HEH, and BM declare that they
have no competing interests.
Authors’ contributions
ML, KMQ, SBC, GJS, MDM, and RMvD designed the synthesizer. ML, KMQ,
SBC, and BM built and tested the synthesizer. HEH contributed key design
elements to the synthesizer and software. ML, KMQ, SBC, MDM, and RMvD
designed the software architecture and user interface. KMQ and SBC
implemented and tested the software. ML, KMQ, and SBC designed and
performed experiments to characterize the synthesizer. ML performed the
radiosyntheses and analyses of synthesis data. JC helped perform the
radiosyntheses and collect specific activity data. MEP, MDM, and RMvD
conceived the project. ML and RMvD wrote the manuscript. All authors read
and approved the final manuscript.
Acknowledgments
This work was supported in part by the Department of Energy Office of
Biological and Environmental Research (DE-SC0001249 and DE-FG02
-06ER64249), the UCLA Foundation from a donation made by Ralph and
Marjorie Crump for the Crump Institute for Molecular Imaging, and Sofie
Biosciences, Inc. We would like to acknowledge Dan Thompson and the rest
of the team at Design Catapult for their insight and creativity in tackling
some of the complex engineering challenges. We greatly appreciate Dr.
Saman Sadeghi and Phillip Marchis for providing D-[18F]FAC from the UCLA
Biomedical Cyclotron Facility; Drs. David Nathanson, Liu Wei, Caius Radu, and
Johannes Czernin for generously supporting the microPET imaging; and Dr.
Nagichettiar Satyamurthy for his invaluable advice.
Author details
1Department of Bioengineering, Henry Samueli School of Engineering, UCLA,
Los Angeles, CA 90095, USA. 2Department of Molecular and Medical
Pharmacology, David Geffen School of Medicine, UCLA, 4323 CNSI, 570
Westwood Plaza, Building 114, Los Angeles, CA 90095, USA. 3Crump Institute
for Molecular Imaging, David Geffen School of Medicine, UCLA, Los Angeles,
CA 90095, USA. 4Sofie Biosciences, Inc., Culver City, CA 90230, USA.
Received: 20 April 2013 Accepted: 2 July 2013
Published: 12 July 2013
References
1. Phelps ME: Positron emission tomography provides molecular imaging of
biological processes. PNAS 2000, 97:9226–9233.
2. Lasne M-C, Perrio C, Rouden J, Barré L, Roeda D, Dolle F, Crouzel C:
Chemistry of β+-emitting compounds based on fluorine-18. In Edited by
Krause W. Edited by Contrast Agents II. Berlin: Springer; 2002:201–258.
3. Weber WA, Figlin R: Monitoring cancer treatment with PET/CT: does it
make a difference? J Nucl Med 2007, 48(Suppl 1):36S–44S.
4. Sachinidis JI, Poniger S, Tochon-Danguy HJ: Automation for optimised
production of fluorine-18-labelled radiopharmaceuticals. Curr Radiopharm
2010, 3:248–253.
5. Keng PY, Esterby M, van Dam RM: Emerging technologies for
decentralized production of PET tracers. In Positron Emission Tomography -
Current Clinical and Research Aspects. Edited by Hsieh CH. Rijeka: InTech;
2012:153–182.
6. Coenen HH, Elsinga PH, Iwata R, Kilbourn MR, Pillai MRA, Rajan MGR,
Wagner HN Jr, Zaknun JJ: Fluorine-18 radiopharmaceuticals beyond [18F]
FDG for use in oncology and neurosciences. Nucl Med Biol 2010,
37:727–740.
7. Alauddin MM, Shahinian A, Gordon EM, Conti PS: Direct comparison of
radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for
HSV1-tk expression in a human breast cancer model. Mol Imaging 2004,
3:76–84.
8. Chin FT, Namavari M, Levi J, Subbarayan M, Ray P, Chen X, Gambhir SS:
Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: a
novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression.
Mol Imaging Biol 2007, 10:82–91.
9. Radu CG, Witte ON, Nair-Gill ED, Satyamurthy N, Shu CJ, Czernin J: Positron
emission tomography probes for imaging immune activation and
selected cancers. 2012. US Patent 8101740.
10. Laing RE, Walter MA, Campbell DO, Herschman HR, Satyamurthy N, Phelps
ME, Czernin J, Witte ON, Radu CG: Noninvasive prediction of tumor
Lazari et al. EJNMMI Research 2013, 3:52 Page 13 of 13
http://www.ejnmmires.com/content/3/1/52responses to gemcitabine using positron emission tomography. Proc Natl
Acad Sci 2009, 106:2847–2852.
11. Alauddin MM, Conti PS, Fissekis JD: Synthesis of [18F]-labeled 2’-deoxy-2’-
fluoro-5-methyl-1-β-D-arabinofuranosyluracil ([18F]-FMAU). J Label Cpd
Radiopharm 2002, 45:583–590.
12. Cai H, Li Z, Conti PS: The improved syntheses of 5-substituted 2′-[18F]
fluoro-2′-deoxy-arabinofuranosyluracil derivatives ([18F]FAU, [18F]FEAU,
[18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU) using a multistep one-
pot strategy. Nucl Med Biol 2011, 38:659–666.
13. Alauddin MM, Fissekis JD, Conti PS: Synthesis of [18F]‐labeled adenosine
analogues as potential PET imaging agents. J Label Compd Radiopharm
2003, 46:805–814.
14. Anderson H, Pillarsetty N, Cantorias M, Lewis JS: Improved synthesis of 2’-
deoxy-2’-[18F]-fluoro-1-[beta]-d-arabinofuranosyl-5-iodouracil ([18F]-
FIAU). Nucl Med Biol 2010, 37:439–442.
15. Paolillo V, Riese S, Gelovani JG, Alauddin MM: A fully automated synthesis
of [18F]-FEAU and [18F]-FMAU using a novel dual reactor radiosynthesis
module. J Label Compd Radiopharm 2009, 52:553–558.
16. Li Z, Cai H, Conti PS: Automated synthesis of 2′-deoxy-2′-[18F]fluoro-5-
methyl-1-β-d-arabinofuranosyluracil ([18F]-FMAU) using a one reactor
radiosynthesis module. Nucl Med Biol 2011, 38:201–206.
17. Amarasekera B, Marchis PD, Bobinski KP, Radu CG, Czernin J, Barrio JR, van
Dam RM: High-pressure, compact, modular radiosynthesizer for production
of positron emitting biomarkers. Appl Radiat Isot 2013, 78:88–101.
18. Herman H, Flores G, Quinn K, Eddings M, Olma S, Moore MD, Ding H,
Bobinski KP, Wang M, Williams D, Williams D, Shen CK, Phelps ME, van Dam
RM: Plug-and-play modules for flexible radiosynthesis. Appl Radiat Isot
2013, 78:113–124.
19. Herman H, Quinn K, Esterby M, Shah GJ, Flores G, Phelps ME, Satyamurthy
N, van Dam RM: Flexible radiosynthesizer capable of multi-pot high
temperature and pressure reactions [abstract]. J Label Compd Radiopharm
2011, 54:s50.
20. Claggett SB, Quinn KM, Lazari M, Moore MD, van Dam RM: Simplified
programming and control of automated radiosynthesizers through unit
operations. EJNMMI Research 2013, 3:53.
21. Moore MD, Quinn K, Claggett S, Lazari M, Shah GJ, Satyamurthy N, Phelps
ME, van Dam RM: ARC-P HS+: a versatile radiosynthesizer for the production of
PET tracers [abstract], American Association for Cancer Research Annual
Meeting: 31 March–4 April 2012; Chicago. Philadelphia: American
Association for Cancer Research; 2012.
22. Iwata R, Yamazaki S, Ido T: Automated injection of a radioactive sample
for preparative HPLC with feedback control. Int J Radiat Appl Instrum Appl
Radiat Isot 1990, 41:1225–1227.
23. Berridge MS, Apana SM, Hersh JM: Teflon radiolysis as the major source of
carrier in fluorine-18. J Label Compd Radiopharm 2009, 52:543–548.
24. Mangner TJ, Klecker RW, Anderson L, Shields AF: Synthesis of 2’-deoxy-2’-
[18F]fluoro-[beta]-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU,
[18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular
proliferation: synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU. Nuc Med
Biol 2003, 30:215–224.
25. Radu CG, Shu CJ, Nair-Gill E, Shelly SM, Barrio JR, Satyamurthy N, Phelps ME,
Witte ON: Molecular imaging of lymphoid organs and immune activation
using positron emission tomography with a new 18F-labeled 2′-
deoxycytidine analog. Nat Med 2008, 14:783–788.
26. Shen B, Lazari M, Maraglia B, Collier L, Hammond K, Moore M, van Dam
RM, Chin FT: Improved [18F]FEAU radiosynthesis on different
automated radiochemistry platforms [abstract]. J Label Compd
Radiopharm 2013, 56:s471.
doi:10.1186/2191-219X-3-52
Cite this article as: Lazari et al.: ELIXYS - a fully automated, three-reactor
high-pressure radiosynthesizer for development and routine production
of diverse PET tracers. EJNMMI Research 2013 3:52.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
